Provisional Agenda
(subject to change)
Day 1: Tuesday 11th September | The Edward Boyle Auditorium, JdP, St Hilda’s College
0830: Registration and welcome coffee
0915: Housekeeping
0920: Opening by Professor Martha Clokie
Session 1: Phage evolution and genetic analysis – Chair: Martha Clockie
0930: Professor Michael Brockhurst, Department of Animal and Plant Sciences, University of Sheffield, Sheffield, UK
Cross-resistance evolution is modular in bacteria-phage communities
1000: Dr Dann Turner, Department of Applied Sciences, University of the West of England, Bristol, UK
The giant Acinetobacter phages
1030: Professor Alfonso Jaramillo, Chair of Synthetic Biology, University of Warwick, Coventry, UK
Directed evolution of biomolecules using phage transduction
1100: Refreshment break, posters and networking
1130: Miss Rosanna Wright, Department of Biology, University of York, York, UK
Multi-phage resistance: the effect of sequential selection
1150: Dr Miguel A Barreto-Sanz, University of Applied Sciences of Western Switzerland, Yverdon-Les-Bains, Switzerland
In-silico prediction of phage-bacteria interactions at a strain-level through omics data analysis and machine learning
1210: Miss Laura Wicke, Institute for Molecular Infection Biology, Würzburg, Germany
Grad-seq analysis of giant bacteriophage phiKZ infecting Pseudomonas aeruginosa
Session 2: Phage-host interaction – Chair: Mathias Middelboe
1230: Mr Artem Isaev, Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia
Characterization of phage defence system BREX from Escherichia coli HS
1250: Miss Tanaporn Phetruen, Department of Biology, Faculty of Science, Mahidol University, Bangkok, Thailand
Identification of host receptor for myovirus specific to Clostridium difficile
1310: Group photo, Lunch, posters and networking
1410: Miss Jóhanna Jørgensen, Department of Biology, University of Copenhagen, Elsinore, Denmark
Loss of virulence in bacteriophage resistant Flavobacterium psychrophilum
1430: Dr Andrew Millard, Dept Genetics and Genome Biology, University of Leicester, Leicester, UK
Engineering bacteriophages to increase their localisation at specific tissue types
Session 3: Biotechnology and commercialisation – Chair: Andrew Miller
1450: Dr Tatiana Lehnherr, Chief Scientific Officer, PTC Phage Technology Center GmbH, Bönen, Germany
Can a phage application reduce E. coli in a chicken shed?
1520: Refreshment break, posters and networking
1600: Dr Ville-Petri Friman, University of York, Department of Biology, York, United Kingdom
Phage selection can constrain plant disease dynamics via resistance-virulence trade-offs
1620: Professor Manickam Ravichandran, COMBio, AIMST University, Kedah, Malaysia
MACERGEN ZAP: Application of phage therapy towards biocontrol of Macergen infestation
1640: Mr Collin Buttimer, Department of Biological Sciences, Cork Institute of Technology, Cork, Ireland
Novel N4-like phages of Pectobacterium atrosepticum
1700: Professor Valery Peternko, Department of Pathobiology, Auburn University, AL, USA
Landscape Phage – From phage display to bioengineering and nanobiotechnology
1720: Dr Philip Webber, Dehns Patent and Trade Mark Attorneys, Oxford, UK
Patenting of phage-based therapies
1750: Mr Frank Kelcz, Adviser to Oxford Global Ventures, Venture Partner, DNCapital, London, UK
Commercialisation resources
1810: End of Day 1
1915: Networking dinner, College Dining Hall (by prior booking or invitation)
Day 2: Wednesday 12th September | The Edward Boyle Auditorium, JdP, St Hilda’s College
Session 4: Therapeutics/antimicrobials – Chair Sivachandran Parimannan
0900: Dr Krystyna Dąbrowska, Poland
Complement system as the factor determining long-circulating or short-circulating phage phenotype
0930: Dr Evelien Adriaenssens, University of Liverpool, UK
Who’s in control, the bacterial host or the resident prophage?
1000: Professor Rob Lavigne (Keynote), Laboratory of Gene Technology, KU Leuven, Belgium
Pseudomonas phage phiKMV: simple phage, intricate examples of host hijacking and regulation
1040: Refreshment break, posters and networking
1110: Professor Martha Clokie, University of Leicester, UK
Updates on our understanding and therapeutic development of Clostridium difficile phages
1140: Professor Aidan Coffey, Dept of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, Ireland
Use of bacteriophage-derived peptidoglycan hydrolase enzymes to eliminate antibiotic resistant Staphylococcus aureus and Clostridium difficile
1210: Dr Robert Atterbury, School of Veterinary Medicine and Science, University of Nottingham, Leicestershire, UK
Revisiting the use of bacteriophage to treat cholera
1240: Lunch, posters and networking
Session 5: Methods, formulation and clinical applications – Chair Aidan Coffey
1330: Dr Saija Kiljunen, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
Towards phage therapy: How to purify phages?
1400: Dr Antonia Sagona, School of Life Sciences, University of Warwick, UK
Fluorescent K1F phage reveals the mechanism of Escherichia coli K1 infection in urinary bladder epithelial cells
1420: Dr Teagan Brown, Department of Pharmacy and Applied Science, La Trobe University, Australia
The formulation of bacteriophages in semi-solid and solid dosage forms to target epithelia
1440: Mr Mohammed Imam, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
Isolation of phages infecting clinical Pseudomonas and Escherichia strains
1500: Miss Scarlet Milo, Department of Chemistry, University of Bath, UK
Development of infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract
1520: Closing remarks by Professor Martha Clokie, discussion and close
